Clinical Trials Sponsored by Fondazione Neureca

Total 2640 results

Fondazione Neureca

Unknown

Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale (IRIS)

Parkinson's Disease

Italy
Neurent Medical

Completed

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

Chronic Rhinitis

United States
Fundació Eurecat

Completed

Collaborative and Adaptive Recommender for Personalized DIEt Management (CarpeDiem)

Physical Activity | Sleep | Life Style, Healthy | Diet Habit

Spain
Neurent Medical

Completed

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (MERIDIEN)

Chronic Rhinitis

United States
Neurent Medical

Active, not recruiting

Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)

Chronic Rhinitis

United States
Fundació Eurecat

Completed

Metabotyping in the Postmenopausal Stage (SHE-HEALTH)

Menopause | Postmenopausal Symptoms | Postmenopausal Disorder

Spain
Neurent Medical

Recruiting

NEUROMARK Randomized Controlled Trial

Chronic Rhinitis

United States
Neurent Medical

Recruiting

NEUROMARK Registry Study

Chronic Rhinitis

United States
NeuTec Pharma

Completed

Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer

Cancer of the Breast

Poland, Serbia
NeuTec Pharma

Completed

Aurograb and Vancomycin in MRSA Infection

Staphylococcal Infections

United Kingdom
Neurana Pharmaceuticals, Inc.

Completed

A Phase 1 PK Study of Tolperisone in Healthy Subjects

Healthy

United States
Neurana Pharmaceuticals, Inc.

Completed

Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

Healthy

United States
Neurana Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm (RESUME-1)

Back Pain | Acute Pain | Back Muscle Spasm | Back Strain | Back Spasm Upper | Muscle Spasm

United States
Neurana Pharmaceuticals, Inc.

Completed

Tolperisone in Acute Muscle Spasm of the Back (STAR)

Back Pain | Low Back Pain | Acute Pain | Muscle Cramp | Back Strain | Muscle Spasm | Back Spasm Upper Back

United States
Nurea

Withdrawn

Comparative Study of a Software With the Gold Standard

Abdominal Aortic Aneurysm (AAA)

France
Nurea

Completed

Validation of a Software and the Follow-up of Anteropoterior Migration of Stent (ASMOT)

Aortic Aneurysm

France
Neuren Pharmaceuticals Limited

Recruiting

An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome (AS-001)

Angelman Syndrome

Australia
Neuren Pharmaceuticals Limited

Active, not recruiting

An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001) (PMS-001)

Phelan-McDermid Syndrome

United States
Eureka Therapeutics Inc.

Terminated

Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma (ET-109)

Hepatocellular Carcinoma | Liver Neoplasm | Liver Cancer | Metastatic Liver Cancer

United States
Neuren Pharmaceuticals Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers

Healthy Volunteers

Australia
Neuren Pharmaceuticals Limited

Completed

Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC (INTREPID2566)

Brain Injuries

United States
Neuren Pharmaceuticals Limited

Completed

Study of NNZ-2566 in Patients With Traumatic Brain Injury (INTREPID2566)

Brain Injuries

United States
Neuren Pharmaceuticals Limited

Recruiting

An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001) (PTHS-001)

Pitt Hopkins Syndrome

United States
Neuren Pharmaceuticals Limited

Terminated

A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI)

Concussion

United States
Neuren Pharmaceuticals Limited

Completed

Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration

Brain Injuries, Traumatic

Australia
Fundació Eurecat
Circe, S.L.

Not yet recruiting

Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2) (BIOPTERO2)

Biological Availability

Spain
Fundació Eurecat
Euromed, S.A.

Not yet recruiting

Effect of Pomanox® on Skin Ageing (POMASKIN) (POMASKIN)

Skin Ageing

Spain
Fundació Eurecat
URIACH, S.L.

Completed

Oral Bioavailability of Two Melatonin Supplements (MELFENIL)

Bioavailability

Spain
Neuren Pharmaceuticals Limited

Recruiting

An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) (PWS-001)

Prader-Willi Syndrome

United States
Eureka Therapeutics Inc.

Recruiting

T-Cell Therapy (ECT204) in Adults With Advanced HCC (ARYA-3)

Hepatocellular Carcinoma | Liver Neoplasm | Metastatic Liver Cancer | Liver Cancer, Adult

United States
Eureka Therapeutics Inc.

Recruiting

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma (ARYA-2)

Liver Neoplasms | Hepatocellular Carcinoma (HCC) | Liver Cancer | Hepatoblastoma | Metastatic Liver Cancer | HEMNOS

United States
Eureka Therapeutics Inc.

Terminated

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

Hepatocellular Carcinoma | Liver Neoplasm | Liver Cancer | Metastatic Liver Cancer

United States
Neuren Pharmaceuticals Limited

Completed

A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

Fragile X Syndrome

United States
Neuren Pharmaceuticals Limited

Completed

Safety Study of NNZ-2566 in Healthy Female Subjects

Brain Injuries, Traumatic

Australia
Fundació Eurecat
Circe, S.L.

Completed

Oral Bioavailability of Pterostilbene Cocrystal Compared to Its Free Form (BIOPTERO) (BIOPTERO)

Biological Availability

Spain
Ureca BV

Terminated

Safety and Efficacy of the URECA CTO Device

Peripheral Vascular Disease

Netherlands
Fondazione Oncotech

Not yet recruiting

NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)

Breast Cancer

Italy
Fondazione Telethon

Enrolling by invitation

Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)

Immunologic Deficiency Syndromes

Italy
Fondazione Fatebenefratelli

Completed

Nutritional Status Evaluation of Hospitalized Patients With Acute Respiratory Failure and COPD

Malnutrition | COPD

Italy
Fondazione Telethon

Unknown

Natural History Study in Subjects With Usher Syndrome

Usher Syndrome, Type 1B

Italy, Netherlands, Spain
Fondazione Michelangelo

Completed

Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors

Solid Tumors

Italy
Fondazione Michelangelo

Completed

Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer (ETNA)

Breast Cancer

Spain, Australia, Singapore, Italy, Germany, Russian Federation
Fondazione Telethon

Withdrawn

Retroviral Insertion Site Methodology Study

Immune System Diseases
Fondazione Telethon

Completed

Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)

Severe Combined Immunodeficiency Due to ADA Deficiency

Italy
Fondazione Telethon

Active, not recruiting

Gene Therapy in Patients With Mucopolysaccharidosis Disease

Mucopolysaccharidosis Type VI

Italy, Turkey
Fondazione Telethon

Completed

Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency. (TIGEM2-PDH)

Pyruvate Dehydrogenase Complex Deficiency

Italy
Fondazione Michelangelo

Terminated

R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma

Hodgkin Lymphoma

United States, Italy
Fondazione Michelangelo

Completed

Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma

Hodgkin Lymphoma

Italy
Fondazione Michelangelo

Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 (NeoTRIPaPDL1)

Invasive Ductal Breast Carcinoma

Spain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
Fondazione Telethon

Active, not recruiting

Methodology Study of Retroviral Insertion Site Analysis in Strimvelis Gene Therapy

Severe Combined Immunodeficiency Due to ADA Deficiency

Italy

Clinical Trials Sponsored by Fondazione Neureca

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations